14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 29 days ( -133.20 % )
Last Price $0.0562 0 %
High/ Low $0.0562 - $0.0562 0%
Chg 7 Days N/A $0.0562 $0.0562
Chg 30 Days 61.96 % $0.0347 $0.0562
Chg 12 mos 21.91 % $0.0461 $0.0562
Trend - 3 mos 286.05 % Width: 72.78 %
Trend - 12 mos -38.10 % Width: 1,177.23 %
Pred. range - 3 mos $0.148 - $0.256 163.69 % - 355.61 %
Pred. range - 12 mos $0.0027 - $0.0347 -95.17 % - -38.25 %
Short MA avg 3 mos Sell Apr 29, 2024 - 15 days
Long MA avg 3 mos Buy Apr 08, 2024 - 30 days
Short/Long MA avg 3 mos Buy Apr 02, 2024 - 34 days
Short MA avg 12 mos Buy Apr 08, 2024 - 30 days
Long MA avg 12 mos Buy Apr 11, 2024 - 27 days
Short/Long MA avg 12 mos Buy Apr 24, 2024 - 18 days
Pivot Short Sell May 16, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Tryp Therapeutics Inc.

Tryp Therapeutics. Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndro... TRYPF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT